Skip to main content

Advertisement

Log in

Systemic pharmacological investigation of the Feng Shi Gu Tong capsule in the treatment of rheumatoid arthritis

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Feng Shi Gu Tong (FSGT) capsule is a commonly used Chinese Traditional Patent Medicine in clinical practice, which has been proven to be effective for the treatment of active rheumatoid arthritis (RA). However, due to its complex composition, the precise molecular mechanism of the FSGT capsule in the treatment of RA is still indistinct. Therefore, the method of systemic pharmacology was used to obtain candidate compounds through absorption, distribution, metabolism, elimination (ADME) parameters, and supplementation of references. Network construction and analysis were also included to reveal the potential mechanism of FSGT capsule in treating RA. A total of 119 compounds were obtained in FSGT capsule, and a total of 107 compounds with targets were included in the study. These compounds acted on 267 targets in total. In addition, there were 317 targets related to RA disease. All constructed networks included four major networks and four minor networks. In addition, the clusters of RA disease protein-protein interaction (PPI) network and FSGT capsule-RA disease targets network revealed that the biological process involved in these clusters including immune response and apoptosis, etc. The pathways enriched by the direct targets of FSGT capsule acted on RA also highly overlapped with the pathways enriched by the RA PPI network, such as the TNF signaling pathway. Our research has managed to predict and explain the pharmacological effects and the molecular mechanisms of the FSGT capsule in RA, and provided a realistic exploration method for studying the potentially active ingredients of traditional Chinese medicines simultaneously.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The authors declare that the data are available.

References

Download references

Acknowledgments

The authors thank Dr. Yingjie Zhao from Anhui Medical University for his assistance in data review.

Funding

This work was supported by grants from the National Natural Science Foundation of China (no. 82071591)

Author information

Authors and Affiliations

Authors

Contributions

XW and WJF conceived and designed the study, WJF, XW, and CL performed research. XW and WJF analyzed the data. RPZ and YC researched the literature. XW wrote the manuscript. WH revised the manuscript. The authors declare that all data were generated in-house and that no paper mill was used. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Wei Hu.

Ethics declarations

Ethical approval

Not applicable

Consent to participate

Not applicable

Consent to publish

Not applicable

Conflict of interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(XLSX 126 kb)

ESM 2

(XLSX 271 kb)

ESM 3

(XLSX 29 kb)

ESM 4

(XLSX 9 kb)

ESM 5

(XLSX 5770 kb)

ESM 6

(XLSX 35 kb)

ESM 7

(XLSX 65 kb)

ESM 8

(XLSX 50 kb)

ESM 9

(XLSX 94 kb)

ESM 10

(XLSX 77 kb)

ESM 11

(XLSX 53 kb)

ESM 12

(XLSX 81 kb)

ESM 13

(XLSX 104 kb)

ESM 14

(XLSX 82 kb)

ESM 15

(PNG 3215 kb)

High resolution image (TIF 30038 kb)

ESM 16

(PNG 1264 kb)

High resolution image (TIF 14411 kb)

ESM 17

(DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, X., Fu, W., Zhou, R. et al. Systemic pharmacological investigation of the Feng Shi Gu Tong capsule in the treatment of rheumatoid arthritis. Naunyn-Schmiedeberg's Arch Pharmacol 394, 1285–1299 (2021). https://doi.org/10.1007/s00210-021-02048-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-021-02048-8

Keywords

Navigation